LuciXaz

Ixazomib Capsules 4mg

,

Description

COMPOSITION:

Each LuciXaz capsule contains: 5.7mg lxazomib citrate equivalent to lxazomib….………4mg

 

INDICATION: 

LuciXaz is a proteasome inhibitor indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.

 

DOSAGE AND USE:

Recommended starting dose of 4 mg taken orally on Days 1, 8, and 15 of a 28-day cycle. Dose should be taken at least one hour before or at least two hours after food.

Capsule should be swallowed whole & not chewed or crushed.

 

STORAGE:

in a dry place and store at 20°C to 25°C.

 

MANUFACTURED AND MARKETED BY: 

LUCIUS PHARMACEUTICALS(LAO) CO., LTD

No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

 

WARNING:

Keep medicine out of the reach of Children. Do not administered LuciXaz in Pregnancy and Lactation patient treatment.

Reviews

There are no reviews yet.

Be the first to review “LuciXaz”

Your email address will not be published. Required fields are marked *